US FDA Vaccination Rate Exceeds 96%, But Will It Lead To More In-Office Work?
Teleworking remains popular among employees and could be a powerful perk to help FDA recruiting.
You may also be interested in...
The agency is considering how to move forward as Pfizer studies a third shot after missing an efficacy endpoint in children age 2 to 5.
CBER director Peter Marks notes efforts to bring in more staff to deal with ‘crushing’ workload; says there has been no political pressure for the center to approve COVID-19 booster shots.
Allergenic extract products, previously excluded, also will become part of the user fee program beginning in FY 2023.